Sees adjusted EBITDA $270M-$286M. Being in the pharmacy space for a long time, I understand the pain points that consumers face in getting access to their medications. I believe GoodRx (GDRX) is poised to leverage its core capabilities, deepen its relationships across the pharmacy ecosystem, and drive to a broader solution set to enhance access to medications at affordable prices for consumers, said Chris McGinnis, Chief Financial Officer and Treasurer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GDRX:
- Notable companies reporting before tomorrow’s open
- GoodRx Holdings: Hold Rating Amid Leadership Changes and Modest Growth Expectations
- GoodRx Holdings Appoints Christopher McGinnis as CFO
- GoodRx names Christopher A. McGinnis as CFO
- Hold Rating for GoodRx Holdings Amidst Leadership Changes and Industry Challenges